BUSINESS China approves two IPOs on sci-tech innovation board


China approves two IPOs on sci-tech innovation board


22:50, June 15, 2019


China Securities Regulatory Commission officially launched the SSE STAR market in Shanghai on June 13. (File photo: VCG)

BEIJING, June 15 (Xinhua) -- China's securities regulator approved the initial public offering (IPO) applications of two companies on the newly launched science and technology innovation board.

Suzhou HYC Technology Co., LTD and Yantai Raytron Technology Co., LTD have become the first two companies approved to be listed on the sci-tech innovation board, the China Securities Regulatory Commission (CSRC) said in a statement Friday night.

It did not specify the total amount of funds to be raised.

The companies and their underwriters will confirm IPO dates and publish their prospectuses following discussions with the stock exchanges.

China inaugurated its science and technology innovation board on Thursday in Shanghai, kicking off the country's much-anticipated capital market reform this year.

The sci-tech innovation board, proposed in November 2018 and approved in January, is designed to focus on companies in the high-tech and strategic emerging sectors, such as new-generation information technology, advanced equipment, new materials, new energy, energy saving and environmental protection and biomedicine, according to the CSRC.

As of June 10, the Shanghai Stock Exchange had handled 119 applications for IPOs on the sci-tech innovation board. Among them, 41 companies, or 34 percent, are in the field of new-generation information technology, 21 in the advanced equipment industry, 27 in biomedicine and 13 in new materials.

Terms of Service & Privacy Policy

We have updated our privacy policy to comply with the latest laws and regulations. The updated policy explains the mechanism of how we collect and treat your personal data. You can learn more about the rights you have by reading our terms of service. Please read them carefully. By clicking AGREE, you indicate that you have read and agreed to our privacy policies

Agree and continue